Dosing of Mefenamic Acid for Reducing Menstrual Bleeding
For reducing menstrual bleeding, mefenamic acid should be dosed at 500 mg initially, followed by 250 mg every 6 hours, taken for 5-7 days starting at the onset of menstruation. 1
Standard Dosing Regimen
The FDA-approved dosing for mefenamic acid is:
- Initial dose: 500 mg orally at onset of bleeding
- Maintenance: 250 mg every 6 hours as needed
- Duration: Treatment should not exceed 2-3 days for dysmenorrhea, though 5-7 days is used for heavy menstrual bleeding 1
Evidence-Based Context
The 2024 CDC guidelines specifically list mefenamic acid among NSAIDs recommended for managing bleeding irregularities, with a treatment duration of 5-7 days 2. This aligns with the broader evidence base showing NSAIDs are effective for menstrual bleeding control.
Efficacy Data
Research demonstrates mefenamic acid's effectiveness:
- Reduces menstrual blood loss by approximately 20% compared to baseline 3
- In contraceptive-related bleeding (DMPA, Norplant, Implanon users), mefenamic acid 500 mg 2-3 times daily for 5 days significantly stops bleeding in 65-76% of women within the first week 4, 5, 6
- Works through improved platelet aggregation and vasoconstriction mechanisms 7
Practical Dosing Variations
While the FDA label specifies 250 mg every 6 hours after the initial 500 mg dose, clinical trials have successfully used:
- 500 mg twice daily for 5 days (for contraceptive-related bleeding) 4
- 500 mg three times daily for 5 days (for Implanon users) 5
- 500 mg twice daily for 5 days (for Norplant users) 6
Clinical Algorithm
When to use:
- Heavy menstrual bleeding without underlying pathology
- Bleeding irregularities with copper IUD, implants, or DMPA
- As first-line medical therapy before considering hormonal options
How to prescribe:
- Start at onset of menstrual bleeding or spotting
- Give 500 mg loading dose
- Continue 250 mg every 6 hours (or 500 mg 2-3 times daily based on severity)
- Treat for 5-7 days maximum per cycle
- Can repeat with subsequent menstrual cycles as needed
Important caveats:
- NSAIDs are less effective than tranexamic acid (which reduces bleeding by 54% vs. 20% for mefenamic acid) 3, 8
- Do not use in patients with renal impairment, active GI disease, or NSAID allergies 1
- Effects are temporary—bleeding typically returns to baseline after treatment cessation 4
- For long-term management, consider tranexamic acid or hormonal therapies as more definitive options 2, 9
Monitoring: Assess response after first treatment cycle. If bleeding remains unacceptable after 2-3 cycles of treatment, consider alternative therapies such as tranexamic acid (1 g every 6 hours for 5 days) or hormonal management 2, 3.